NCT00764751View on ClinicalTrials.gov

Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Psoriasis Vulgaris
Interventions
DRUG

LEO 19123 Cream (calcipotriol plus LEO 80122)

Once daily application

DRUG

Dovonex® cream

Twice daily application

DRUG

Cream vehicle

Twice daily application

Trial Locations (1)

L4M 6L2

UltraNova Skincare, Barrie

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT00764751 - Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris | Biotech Hunter | Biotech Hunter